Summary
The product DE, submitted for analysis by mintanabolics@protonmail.com, underwent independent testing to verify its composition and potency. The sample was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The test confirmed the presence of Drostanolone Enanthate, with a measured concentration of 201.16 mg/ml.
The testing process began on 15 August 2024, with the sample received on 26 August 2024, and analysis completed on 27 August 2024. While the results confirm the product’s content, the lack of manufacturer and batch information raises concerns regarding product traceability and consistency. Independent third-party testing remains crucial for comprehensive validation. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Mint Anabolics
- Product Name: DE
- Active Ingredient: Drostanolone Enanthate
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Not specified
Sample Acquisition and Testing
- Task Number: #47970
- Testing Ordered: 15 August 2024
- Sample Received: 26 August 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Mint Anabolics (Manufacturer)
- Analysis Paid For By: Mint Anabolics (Manufacturer)
Testing Results
- Tested Compound: Drostanolone Enanthate
- Measured Concentration: 201.16 mg/ml
Verification Details
Verification URL: https://janoshik.com/tests/47970_MV8YMER954QQ
Evaluation of Manufacturer-Submitted Testing
While this analysis confirms the presence and concentration of Drostanolone Enanthate, the lack of manufacturer and batch information raises concerns about product traceability and consistency. The absence of these key details makes it difficult to assess quality control standards over time. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, independent validation through third-party testing remains essential.
Conclusion
The analysis confirms that the sample contains Drostanolone Enanthate at 201.16 mg/ml. However, without a specified manufacturer or batch number, further verification is necessary to ensure reliability and consistency across different samples. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
